CY1106086T1 - Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα - Google Patents
Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογοναInfo
- Publication number
- CY1106086T1 CY1106086T1 CY20061100500T CY061100500T CY1106086T1 CY 1106086 T1 CY1106086 T1 CY 1106086T1 CY 20061100500 T CY20061100500 T CY 20061100500T CY 061100500 T CY061100500 T CY 061100500T CY 1106086 T1 CY1106086 T1 CY 1106086T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methylon
- androgens
- beta
- substituted
- preparation
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title 1
- 229940030486 androgens Drugs 0.000 title 1
- 150000003431 steroids Chemical class 0.000 abstract 2
- 206010002261 Androgen deficiency Diseases 0.000 abstract 1
- 230000001548 androgenic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99204080 | 1999-12-02 | ||
| EP00993259A EP1237904B1 (en) | 1999-12-02 | 2000-11-29 | 14,15-beta-methylene substituted androgens |
| PCT/EP2000/012009 WO2001040255A2 (en) | 1999-12-02 | 2000-11-29 | 14,15-beta-methylene substituted androgens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106086T1 true CY1106086T1 (el) | 2011-06-08 |
Family
ID=8240955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061100500T CY1106086T1 (el) | 1999-12-02 | 2006-04-10 | Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6706700B2 (https=) |
| EP (1) | EP1237904B1 (https=) |
| JP (1) | JP2003515543A (https=) |
| CN (1) | CN1166680C (https=) |
| AR (1) | AR026655A1 (https=) |
| AT (1) | ATE317396T1 (https=) |
| AU (1) | AU778017B2 (https=) |
| CA (1) | CA2390226A1 (https=) |
| CO (1) | CO5251441A1 (https=) |
| CY (1) | CY1106086T1 (https=) |
| CZ (1) | CZ301376B6 (https=) |
| DE (1) | DE60025958T2 (https=) |
| DK (1) | DK1237904T3 (https=) |
| ES (1) | ES2258037T3 (https=) |
| HK (1) | HK1047596B (https=) |
| HU (1) | HUP0203611A3 (https=) |
| IL (1) | IL149424A (https=) |
| MX (1) | MXPA02004939A (https=) |
| NO (1) | NO322422B1 (https=) |
| NZ (1) | NZ518753A (https=) |
| PE (1) | PE20011033A1 (https=) |
| PL (1) | PL202999B1 (https=) |
| RU (1) | RU2242479C2 (https=) |
| SK (1) | SK287095B6 (https=) |
| TW (1) | TWI275593B (https=) |
| WO (1) | WO2001040255A2 (https=) |
| ZA (1) | ZA200203536B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1212345B1 (en) * | 1999-04-06 | 2003-08-06 | Akzo Nobel N.V. | Orally active 7-alpha-alkyl androgens |
| US20050090476A1 (en) * | 2002-01-21 | 2005-04-28 | Arnoldus Maria Van Buggenum Patrick | Process for the preparation of 7alpha-methylsteroids |
| US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| RS55231B1 (sr) * | 2011-10-07 | 2017-02-28 | Estetra Sprl | Postupak proizvodnje estetrola |
| DK3701944T3 (da) | 2015-06-18 | 2022-03-14 | Estetra Srl | Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent |
| LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| CR20180042A (es) | 2015-06-18 | 2018-05-03 | Mithra Pharmaceuticals S A | Unidad de dosificación orodispersable que contiene un componente estetrol. |
| KR102712911B1 (ko) | 2016-08-05 | 2024-10-04 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| CN111989105B (zh) | 2018-04-19 | 2024-07-19 | 埃斯特拉私人有限责任公司 | 化合物以及它们在缓解绝经相关症状中的用途 |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| CN111621141B (zh) * | 2020-06-12 | 2022-04-08 | 广西大学 | 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3086027A (en) * | 1960-01-22 | 1963-04-16 | Lilly Co Eli | 19-nor-4, 9(10)-steroids and process |
| IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
| DE19537626A1 (de) | 1995-10-10 | 1997-04-17 | Jenapharm Gmbh | Steroide mit einer 14, 15-Methylengruppe |
| DE19827522A1 (de) | 1998-06-22 | 1999-12-23 | Jenapharm Gmbh | 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| EP1163259B1 (en) | 1999-03-08 | 2002-11-20 | Akzo Nobel N.V. | 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
-
2000
- 2000-11-29 ES ES00993259T patent/ES2258037T3/es not_active Expired - Lifetime
- 2000-11-29 RU RU2002117440/04A patent/RU2242479C2/ru not_active IP Right Cessation
- 2000-11-29 CN CNB008164959A patent/CN1166680C/zh not_active Expired - Fee Related
- 2000-11-29 SK SK758-2002A patent/SK287095B6/sk not_active IP Right Cessation
- 2000-11-29 IL IL149424A patent/IL149424A/en not_active IP Right Cessation
- 2000-11-29 AT AT00993259T patent/ATE317396T1/de not_active IP Right Cessation
- 2000-11-29 HK HK02109169.4A patent/HK1047596B/en not_active IP Right Cessation
- 2000-11-29 DE DE60025958T patent/DE60025958T2/de not_active Expired - Lifetime
- 2000-11-29 EP EP00993259A patent/EP1237904B1/en not_active Expired - Lifetime
- 2000-11-29 AU AU28383/01A patent/AU778017B2/en not_active Ceased
- 2000-11-29 JP JP2001541010A patent/JP2003515543A/ja active Pending
- 2000-11-29 NZ NZ518753A patent/NZ518753A/en unknown
- 2000-11-29 DK DK00993259T patent/DK1237904T3/da active
- 2000-11-29 CA CA002390226A patent/CA2390226A1/en not_active Abandoned
- 2000-11-29 CZ CZ20021894A patent/CZ301376B6/cs not_active IP Right Cessation
- 2000-11-29 MX MXPA02004939A patent/MXPA02004939A/es active IP Right Grant
- 2000-11-29 WO PCT/EP2000/012009 patent/WO2001040255A2/en not_active Ceased
- 2000-11-29 US US10/148,820 patent/US6706700B2/en not_active Expired - Fee Related
- 2000-11-29 PL PL355689A patent/PL202999B1/pl not_active IP Right Cessation
- 2000-11-29 HU HU0203611A patent/HUP0203611A3/hu unknown
- 2000-11-30 AR ARP000106304A patent/AR026655A1/es active IP Right Grant
- 2000-12-01 CO CO00092012A patent/CO5251441A1/es not_active Application Discontinuation
- 2000-12-01 PE PE2000001285A patent/PE20011033A1/es not_active Application Discontinuation
- 2000-12-02 TW TW089125707A patent/TWI275593B/zh not_active IP Right Cessation
-
2002
- 2002-05-03 ZA ZA200203536A patent/ZA200203536B/en unknown
- 2002-05-30 NO NO20022564A patent/NO322422B1/no not_active IP Right Cessation
-
2006
- 2006-04-10 CY CY20061100500T patent/CY1106086T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106086T1 (el) | Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα | |
| ES2174629T3 (es) | 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos. | |
| CY1109404T1 (el) | Μεθοδος δια την παρασκευη προϊοντων στεροειδους ορμονης. η οποια περιλαμβανει παραγοντα σταθεροποιησεως εις μη-κρυσταλλικην μορφη | |
| IL146281A0 (en) | Indoline derivatives as progesterone antagonists | |
| HUP0104718A2 (hu) | Mikronizált eplerenon kompozíciók és eljárás az előállításukra | |
| CY1105931T1 (el) | Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας | |
| ECSP083351A (es) | Composiciones farmacéuticas | |
| TR199800648A1 (xx) | �ki veya daha fazla etken madde i�in ila� verme sistemi. | |
| TR200101822T2 (tr) | Kontrollü salınan galantamin bileşimi | |
| CY1105065T1 (el) | Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση | |
| MY111841A (en) | Injectable liposomal pharmaceutical preparations | |
| NO965516L (no) | Sterolderivater anvendt til regulering av meiose | |
| DE60330695D1 (de) | Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate | |
| ATE212351T1 (de) | Androsten-derivate | |
| FI20011703A7 (fi) | Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä | |
| CY1110637T1 (el) | Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης | |
| IL139861A (en) | 17beta-AMINO-AND HYDROXYLAMINO -11 beta - ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| ATE225800T1 (de) | Nichtestrogene derivate des estradiols mit antioxidativer aktivität | |
| DK0825865T3 (da) | Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat | |
| ATE160573T1 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung | |
| CY1105168T1 (el) | Διφασικη συνθεση με τραμαδολη | |
| BG104424A (en) | Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride | |
| AR022852A1 (es) | Nuevos androgenos | |
| TR199802496T2 (xx) | Konjestif kalp yetmezli�ini tedavi i�in form�lasyon. | |
| SE9803107D0 (sv) | Novel Compunds |